Rheumatoid Arthritis News

Rheumatoid arthritis, an autoimmune disease that affects approximately 1.3 million adults in the United States, can cause pain, disability and long-term joint damage. Depression, another debilitating and disruptive condition, was identified in 8.1% of Americans aged 20 years and older during a 2-week period between 2013 and 2016.

The FDA has accepted for review a Biologics License Application from Samsung Bioepis for its Humira biosimilar, according to a company press release.

The results of an international, EULAR task force survey indicate that rheumatologists varied widely on the identifiable characteristics of difficult-to-treat rheumatoid arthritis, according to findings published in the Annals of the Rheumatic Diseases.

An international group of researchers proposed a more “refined” definition of autoinflammatory diseases and also proposed changes to the naming convention for these diseases, according to a report in Annals of the Rheumatic Diseases.

A study published in the International Journal of Geriatric Psychiatry reported that arthritis was highly prevalent among older adults with varying degrees of depression.

Chronic inflammatory diseases, such as rheumatoid arthritis, psoriasis, psoriatic arthritis, vasculitis and axial spondyloarthritis, represent a group of clinically heterogenous disorders that share a similar immunopathology. Untreated immune-mediated inflammatory diseases (IMIDs) can lead to devastating consequences. This educational activity, led by an expert rheumatologist, addresses the underlying pathogenesis of IMIDs and the utilization of TNF and IL-6 inhibitors.

Mr. J., a 55-year-old retired fireman, was diagnosed with rheumatoid arthritis (RA) 8 years ago (seropositive for both rheumatoid factor [RF] and anti-cyclic citrullinated peptide [anti-CCP]) and started on therapy with methotrexate (MTX) 17.5 mg weekly.

The increased risk for preterm delivery among pregnant woman with rheumatoid arthritis and juvenile idiopathic arthritis is partially tied to maternal disease activity and corticosteroid use, according to data published in Arthritis Care & Research.

Exagen Diagnostics has announced the launch of the first validated blood test to detect anticarbamylated protein antibodies, which have been found to be significantly elevated in patients with rheumatoid arthritis, according to a press release.

Individuals with chronic inflammatory diseases continuously fight several adversaries, including pain, loss of functionality and complications due to treatment. Women of childbearing age who wish to start families can add two more opponents to that list: fear and misinformation.